Rebaudioside A

Cat. No.: 0225LY-0711

Appearance: Solid

Purity: ≥99%

Identity: Confirmed by NMR, HPLC, and LC-MS.

Size:

INQUIRY Datasheet MSDS

Add to basket

Product Overview

Description: Rebaudioside A is a novel glycoside-based clathrating agent that functions as an inhibitor of alpha-glucosidase.

Synonym: 58543-16-1; Stevioside A3; 19-O-beta-glucopyranosyl-13-O-(beta-glucopyranosyl(1-2)-beta-glucopyranosyl(1-3))-beta-glucopyranosyl-13-hydroxykaur-16-en-19-oic acid; [(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1R,4S,5R,9S,10R,13S)-13-[(2S,3R,4S,5R,6R)-5-hydroxy-6-(hydroxymethyl)-3,4-bis[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]oxan-2-yl]oxy-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.01,10.04,9]hexadecane-5-carboxylate

CAS No.: 58543-16-1

Compound CID: 6918840

Formula: C₄₄H₇₀O₂₃

Formula Weight: 967.01

Specification

Targets&IC50: α-glucosidase: 35.01 ug/mL

Relative Density: 1.58 g/cm³

Stability: 3 years in powder form.

Storage: Storage at -20°C.

Applications: Rebaudioside A can be used in nutritional science to study the metabolic effects of high-potency natural sweeteners on insulin response.